πŸ‡ΊπŸ‡Έ FDA
Patent

US 10501507

Griffithsin mutants

granted A61KA61K38/00A61K38/16

Quick answer

US patent 10501507 (Griffithsin mutants) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61K38/16